Green Thumb Industries Inc
CNSX:GTII
Relative Value
The Relative Value of one GTII stock under the Base Case scenario is hidden CAD. Compared to the current market price of 9.55 CAD, Green Thumb Industries Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
GTII Competitors Multiples
Green Thumb Industries Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
G
|
Green Thumb Industries Inc
CNSX:GTII
|
2.3B CAD | 1.4 | 37.1 | 4.7 | 9.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
994.4B USD | 15.3 | 48.2 | 32.5 | 34.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
571B USD | 6.1 | 21.3 | 14.8 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.2B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.1B CHF | 5.3 | 21.2 | 13.1 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.7B GBP | 5.1 | 31.7 | 15.1 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.1B USD | 4.5 | 16 | 10 | 11.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.6 | 13.8 | 10.1 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.4 | 19.7 | 7.4 | 9.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD | 2.6 | 17.6 | 6.9 | 8.8 |